Inhibrx Biosciences, Inc. (INBX)
82.21
-2.30
(-2.72%)
USD |
NASDAQ |
Dec 11, 16:00
82.35
+0.14
(+0.17%)
After-Hours: 07:07
Inhibrx Biosciences Total Assets (Quarterly): 177.47M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 233.89M |
| Ligand Pharmaceuticals, Inc. | 1.477B |
| Armata Pharmaceuticals, Inc. | 89.52M |
| Adverum Biotechnologies, Inc. | 72.40M |
| Pelthos Therapeutics, Inc. | 126.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 140.64M |
| Shareholders Equity (Quarterly) | 36.83M |
| Debt to Equity Ratio | 2.903 |
| Current Ratio | 4.486 |
| Net Debt Paydown Yield | -4.30% |